Cardio Diagnostics Holdings Stock Market Outlook
| CDIO Stock | USD 1.32 0.05 3.65% |
About 59% of all Cardio Diagnostics' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Cardio Diagnostics Holdings suggests that some traders are interested. Cardio Diagnostics' investing sentiment overview a quick insight into current market opportunities from investing in Cardio Diagnostics Holdings. Many technical investors use Cardio Diagnostics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 59
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Cardio Diagnostics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Cardio Diagnostics Holdings.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Cardio Diagnostics Holdings is 'Cautious Hold'. The recommendation algorithm takes into account all of Cardio Diagnostics' available fundamental, technical, and predictive indicators you will find on this site.
Execute Cardio Diagnostics Advice
The Cardio recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Cardio Diagnostics Holdings. Macroaxis does not own or have any residual interests in Cardio Diagnostics Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cardio Diagnostics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Weakest | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Risky | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon Cardio Diagnostics Holdings has a Mean Deviation of 5.58, Standard Deviation of 7.84 and Variance of 61.4We provide trade advice to complement the prevailing expert consensus on Cardio Diagnostics. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Cardio Diagnostics is not overpriced, please confirm all Cardio Diagnostics fundamentals, including its revenue, book value per share, total asset, as well as the relationship between the cash and equivalents and target price . Given that Cardio Diagnostics is a hitting penny stock territory we recommend to closely look at its number of shares shorted.
Cardio Diagnostics Trading Alerts and Improvement Suggestions
| Cardio Diagnostics generated a negative expected return over the last 90 days | |
| Cardio Diagnostics has high historical volatility and very poor performance | |
| Cardio Diagnostics may become a speculative penny stock | |
| Cardio Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 34.89 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 15.78 K. | |
| Cardio Diagnostics Holdings currently holds about 9.66 M in cash with (4.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cardio Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Bull Run What is the earnings history of Cardio Diagnostics Holdings Inc - Market Growth Review AI Powered Buy and Sell Recommendations - baoquankhu1.vn |
Cardio Diagnostics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cardio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cardio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Cardio Diagnostics Returns Distribution Density
The distribution of Cardio Diagnostics' historical returns is an attempt to chart the uncertainty of Cardio Diagnostics' future price movements. The chart of the probability distribution of Cardio Diagnostics daily returns describes the distribution of returns around its average expected value. We use Cardio Diagnostics Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cardio Diagnostics returns is essential to provide solid investment analysis for Cardio Diagnostics.
| Mean Return | -1.26 | Value At Risk | -13.93 | Potential Upside | 14.54 | Standard Deviation | 7.84 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cardio Diagnostics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cardio Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Cardio Diagnostics, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Cardio Diagnostics Holdings back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Sbi Securities Co Ltd | 2025-06-30 | 70.0 | Bank Of America Corp | 2025-06-30 | 15.0 | Srs Capital Advisors Inc | 2025-06-30 | 6.0 | Fmr Inc | 2025-06-30 | 3.0 | Citigroup Inc | 2025-03-31 | 0.0 | Millennium Management Llc | 2025-03-31 | 0.0 | Scientech Research Llc | 2025-03-31 | 0.0 | Endowment Wealth Management, Inc. | 2025-06-30 | 0.0 | Lpl Financial Corp | 2025-06-30 | 0.0 | Blackrock Inc | 2025-06-30 | 35.6 K | Geode Capital Management, Llc | 2025-06-30 | 13.4 K |
Cardio Diagnostics Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Investments | (364.0K) | (368.0K) | (229.9K) | (404.2K) | (363.8K) | (382.0K) | |
| Change In Cash | 275.7K | 3.6M | (2.8M) | 6.5M | 7.5M | 7.9M | |
| Free Cash Flow | (699.3K) | (5.1M) | (6.5M) | (5.4M) | (4.9M) | (5.1M) | |
| Other Non Cash Items | (3.3K) | 112.5K | 1.1M | 1.0 | 1.15 | 1.09 | |
| Capital Expenditures | 114.0K | 2.0 | 794.3K | 404.2K | 464.8K | 295.3K | |
| Net Income | (620.4K) | (4.7M) | (8.4M) | (8.4M) | (7.5M) | (7.2M) | |
| End Period Cash Flow | 512.8K | 4.1M | 1.3M | 7.8M | 9.0M | 9.5M |
Cardio Diagnostics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cardio Diagnostics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cardio Diagnostics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cardio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.63 | |
β | Beta against Dow Jones | 3.81 | |
σ | Overall volatility | 8.13 | |
Ir | Information ratio | -0.17 |
Cardio Diagnostics Volatility Alert
Cardio Diagnostics Holdings is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cardio Diagnostics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cardio Diagnostics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cardio Diagnostics Fundamentals Vs Peers
Comparing Cardio Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cardio Diagnostics' direct or indirect competition across all of the common fundamentals between Cardio Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cardio Diagnostics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cardio Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cardio Diagnostics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cardio Diagnostics to competition |
| Fundamentals | Cardio Diagnostics | Peer Average |
| Return On Equity | -1.11 | -0.31 |
| Return On Asset | -0.62 | -0.14 |
| Operating Margin | (599.51) % | (5.51) % |
| Current Valuation | (3.44 M) | 16.62 B |
| Shares Outstanding | 1.83 M | 571.82 M |
| Shares Owned By Insiders | 6.79 % | 10.09 % |
| Shares Owned By Institutions | 6.35 % | 39.21 % |
| Number Of Shares Shorted | 144.49 K | 4.71 M |
| Price To Book | 0.30 X | 9.51 X |
| Price To Sales | 158.52 X | 11.42 X |
| Revenue | 34.89 K | 9.43 B |
| Gross Profit | 15.78 K | 27.38 B |
| EBITDA | (8.09 M) | 3.9 B |
| Net Income | (8.38 M) | 570.98 M |
| Cash And Equivalents | 9.66 M | 2.7 B |
| Cash Per Share | 5.08 X | 5.01 X |
| Total Debt | 969.86 K | 5.32 B |
| Current Ratio | 18.42 X | 2.16 X |
| Book Value Per Share | 4.61 X | 1.93 K |
| Cash Flow From Operations | (4.99 M) | 971.22 M |
| Short Ratio | 0.13 X | 4.00 X |
| Earnings Per Share | (11.91) X | 3.12 X |
| Target Price | 60.0 | |
| Number Of Employees | 13 | 18.84 K |
| Beta | 2.87 | -0.15 |
| Market Capitalization | 2.5 M | 19.03 B |
| Total Asset | 10.62 M | 29.47 B |
| Retained Earnings | (22.75 M) | 9.33 B |
| Working Capital | 8.16 M | 1.48 B |
| Net Asset | 10.62 M |
Note: Acquisition by Burton Paul Frederick of 2306 shares of Cardio Diagnostics at 2.71 subject to Rule 16b-3 [view details]
Cardio Diagnostics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cardio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 8792.7 | |||
| Daily Balance Of Power | (0.25) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 1.38 | |||
| Day Typical Price | 1.36 | |||
| Price Action Indicator | (0.09) | |||
| Period Momentum Indicator | (0.05) |
About Cardio Diagnostics Buy or Sell Advice
When is the right time to buy or sell Cardio Diagnostics Holdings? Buying financial instruments such as Cardio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cardio Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials ETFs Thematic Idea Now
Financials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Cardio Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Will Biotechnology sector continue expanding? Could Cardio diversify its offerings? Factors like these will boost the valuation of Cardio Diagnostics. Projected growth potential of Cardio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cardio Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (11.91) | Revenue Per Share | Quarterly Revenue Growth (0.57) | Return On Assets | Return On Equity |
Cardio Diagnostics's market price often diverges from its book value, the accounting figure shown on Cardio's balance sheet. Smart investors calculate Cardio Diagnostics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Cardio Diagnostics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cardio Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardio Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.